CRP and cardiovascular disorder: Furthermore, recent evidence has also demonstrated that inflammatory markers such as high sensitivity C-reactive protein (hsCRP)—may not accurately predict cardiovascular disease risk in inflammatory disease states such as systemic lupus erythematosus [26], psoriasis [27], and rheumatoid arthritis [28].